Observational studyFrontiers in endocrinology2022

Efficacy and Safety of Semaglutide for the Management of Obese Patients With Type 2 Diabetes and Chronic Heart Failure in Real-World Clinical Practice.

Luis M Pérez-Belmonte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.